Presence of platelet-activating factor in nasal polyps and eosinophils

Acta Oto-Laryngologica

Volumn 122, Issue 8, 2002, Pages 872-876

  Furukawa, Masayuki ^a   Ogura, Manabu ^a   Tsutsumi, Toshiyuki ^a   Tsuji, Hiroyuki ^a   Yamashita, Toshio ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Aspirin sensitive asthma; Chronic sinusitis; Eosinophils; Nasal polyps; Peptide leukotrienes; Platelet activating factor

Indexed keywords

ACETYLSALICYLIC ACID; LEUKOTRIENE; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; ARTICLE; ASTHMA; CELL COUNT; CELL INFILTRATION; CHRONIC SINUSITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHILIA; HUMAN; HUMAN TISSUE; INFLAMMATION; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

ASPIRIN; ASTHMA; CHROMATOGRAPHY, THIN LAYER; DRUG HYPERSENSITIVITY; EOSINOPHILS; HUMANS; LEUKOCYTE COUNT; LEUKOTRIENES; NASAL MUCOSA; NASAL POLYPS; PLATELET ACTIVATING FACTOR; RADIOIMMUNOASSAY;

EID: 0036965812     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655402/000028064     Document Type: Article

References (22)

1. Bernstein JM. Role of allergy in nasal polyposis: a review. Otolaryngol Head Neck Surg 1995; 113: 724-32.
2. Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol (Stockh) 1996; 116: 160-3.
3. Furukawa M, Horii T, Oda M, Satouchi K, Saito K. PAF in human respiratory diseases. J Lipid Mediat 1992; 5: 191-2.
4. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990; 295: 17381-4.
5. Furukawa M, Yamashita T, Kumazawa T, Satouchi K, Saito K. Evidence of platelet-activating factor in nasal polyps. ORL J Otorhinolaryngol Relat Spec 1992; 54: 29-32.
6. Stoop AE, Harry A, van der Heijden JB, van der Baan S. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. J Allergy Clin Immunol 1993; 91: 616-22.
7. Zoratti EM, Sedgwick JB, Vrtis RR, Busse WW. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. J Allergy Clin Immunol 1991; 88: 749-58.
8. Weller PF, Bozza PT, Yu W, Dvorak AM. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Allergology Int 1997; 46: 141-53.
9. Wardlaw AJ, Moqbel R, Cromwell O, Kay AB. Platelet-activating factor. A potent chemotactic and chemokinetic for human eosinophils. J Clin Invest 1986; 78: 1701-6.
10. Terashita Z, Tsushima S, Yoshioka Y, Nomura H, Inada Y, Nishikawa K. CV-3988 a specific antagonist of platelet-activating factor (PAF). Life Sci 1983; 32: 1975-82.
11. Hwang S-B, Lam M-H, Bftu T, Beattie TR, Shen T-Y. Trans-2,5-bis-(3,4,5-trimethoxyphenyl) tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet-activating factor. J Biol Chem 1985; 260: 15639-45.
12. Furukawa M, Kubo N, Yamashita T. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Laryngoscope 1995; 105: 188-91.
13. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Physiol 1959; 37: 911-7.
14. Bartlett GR. Phosphorous assay in chromatography. J Biol Chem 1959; 234: 466-8.
15. Pinckkard RN, Farr RS, Hanahan DJ. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol 1979; 123: 1847-57.
16. Oda M, Satouchi K, Yasunaga K, Satouchi K. Polymorphonuclear leukocyte-platelet interactions: acetyl-glyceryl ester phosphocholine-induced platelet activation under stimulation with chemotactic peptide. J Biochem (Tokyo) 1986; 100: 1117-23.
17. Nakagawa N, Obata T, Kobayashi T, et al. Effect of peptide leukotriene receptor antagonist, ONO-1078, on guinea-pig models of asthma. Eur J Pharmacol 1993; 265: 211-9.
18. Jung TTK, Juhn SK, Hwang D, Stewart R. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184-9.
19. Kaliner M, Wasserman SL, Austen KF. Immunologic release of chemical mediators from human nasal polyps. N Engl J Med 1973; 289: 277-81.
20. Inoue H, Ganbo T, Hisamitsu K, Ishida H. Study on the metabolism of lyso-platelet activating factor (lyso-PAF) in human paranasal sinus mucosa. The cultured ciliated epithelium can convert lyso-PAF to PAF. Life Sci 1993; 52: 227-32.
21. Yamashita T, Tsuji H, Maeda N, Tomoda K, Kumazawa T. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinology 1989; 8 (Suppl): 15-24.
22. Ogata N, Masayama K, Yoshida M, et al. Evidence for interleukin-5 in nasal polyp in aspirin-induced asthma. Allergology Int 1997; 46: 161-5.